NEXT Financial Group Inc Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

NEXT Financial Group Inc boosted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,040 shares of the medical research company’s stock after buying an additional 36 shares during the quarter. NEXT Financial Group Inc’s holdings in Thermo Fisher Scientific were worth $663,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in TMO. BlackRock Inc. increased its stake in Thermo Fisher Scientific by 1.4% in the second quarter. BlackRock Inc. now owns 27,643,905 shares of the medical research company’s stock valued at $8,118,461,000 after purchasing an additional 392,227 shares during the period. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Thermo Fisher Scientific by 0.6% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,683,947 shares of the medical research company’s stock valued at $490,483,000 after purchasing an additional 10,168 shares during the period. Parametric Portfolio Associates LLC increased its stake in Thermo Fisher Scientific by 3.3% in the third quarter. Parametric Portfolio Associates LLC now owns 1,203,808 shares of the medical research company’s stock valued at $350,633,000 after purchasing an additional 37,955 shares during the period. California Public Employees Retirement System increased its stake in Thermo Fisher Scientific by 28.2% in the third quarter. California Public Employees Retirement System now owns 893,555 shares of the medical research company’s stock valued at $260,266,000 after purchasing an additional 196,657 shares during the period. Finally, California State Teachers Retirement System increased its stake in Thermo Fisher Scientific by 1.0% in the third quarter. California State Teachers Retirement System now owns 721,001 shares of the medical research company’s stock valued at $210,006,000 after purchasing an additional 6,824 shares during the period. 88.31% of the stock is owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific stock opened at $335.38 on Friday. Thermo Fisher Scientific Inc. has a 52-week low of $235.90 and a 52-week high of $342.26. The company has a quick ratio of 1.23, a current ratio of 1.80 and a debt-to-equity ratio of 0.56. The company’s 50-day simple moving average is $326.72 and its 200-day simple moving average is $299.56. The firm has a market cap of $136.36 billion, a price-to-earnings ratio of 37.68, a price-to-earnings-growth ratio of 2.00 and a beta of 1.12.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, October 23rd. The medical research company reported $2.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.88 by $0.06. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.16%. The business had revenue of $6.27 billion for the quarter, compared to analyst estimates of $6.19 billion. During the same period in the previous year, the business posted $2.62 earnings per share. The business’s revenue was up 5.9% compared to the same quarter last year. Equities research analysts anticipate that Thermo Fisher Scientific Inc. will post 12.33 EPS for the current year.

Thermo Fisher Scientific declared that its Board of Directors has initiated a share repurchase program on Friday, November 8th that permits the company to buyback $2.50 million in outstanding shares. This buyback authorization permits the medical research company to purchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

The company also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 17th were paid a dividend of $0.19 per share. The ex-dividend date of this dividend was Monday, December 16th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.23%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 6.83%.

A number of research analysts have commented on TMO shares. Evercore ISI upgraded shares of Thermo Fisher Scientific to an “outperform” rating in a research note on Thursday, November 14th. Needham & Company LLC started coverage on shares of Thermo Fisher Scientific in a research note on Friday, January 3rd. They issued a “strong-buy” rating and a $271.00 price objective on the stock. Stifel Nicolaus started coverage on shares of Thermo Fisher Scientific in a research note on Thursday, November 14th. They issued a “buy” rating and a $345.00 price objective on the stock. Robert W. Baird lifted their price objective on shares of Thermo Fisher Scientific from $305.00 to $319.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Citigroup started coverage on shares of Thermo Fisher Scientific in a research note on Monday, January 6th. They issued a “buy” rating and a $380.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $325.33.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Further Reading: What are gap-down stocks?

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.